4’-Hydroxy Dutasteride - Request Quote
4’-Hydroxy Dutasteride
| SZ CAT No: | SZ-D017018 |
| CAS No | NA |
| Mol.F. | C27H30F6N2O3 |
| Mol.Wt. | 544.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
4’-Hydroxy Dutasteride is chemically (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(4-Hydroxy-2,5-bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide. 4’-Hydroxy Dutasteride is supplied with detailed characterization data compliant with regulatory guideline. 4’-Hydroxy Dutasteride can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dutasteride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality 4’-Hydroxy Dutasteride
Purchase 4’-Hydroxy Dutasteride
4’-Hydroxy Dutasteride suppliers
4’-Hydroxy Dutasteride manufacturers
4’-Hydroxy Dutasteride price
Order 4’-Hydroxy Dutasteride
Enquire 4’-Hydroxy Dutasteride
4’-Hydroxy Dutasteride cost
4’-Hydroxy Dutasteride Supplier
4’-Hydroxy Dutasteride Distributor
4’-Hydroxy Dutasteride for Method Validation
Dutasteride Reference Standard
4’-Hydroxy Dutasteride for ANDA Filing
4’-Hydroxy Dutasteride for Forced Degradation Studies
4’-Hydroxy Dutasteride Identification Standards
4’-Hydroxy Dutasteride for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.